JUST IN: CDC advisers recommend certain adults vaccinated with Pfizer's Covid-19 vaccine get a booster dose
Late on Wednesday, the US Food and Drug Administration authorized giving boosters to people 65 and older and those at higher risk of severe disease and death, as well as people such as health care workers at higher risk of breakthrough infections because of their work. FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and olderMembers of CDC's Advisory Committee on Immunization Practices met Thursday to decide who they should be recommended to.
The advisers also voted 13-2 Thursday to endorse giving booster doses of Pfizer's Covid-19 vaccine to people ages 50 to 64 with underlying medical conditions.But that was short of the FDA's emergency use authorization, which OK'd giving boosters to anyone 18 and older at high risk of severe disease from breakthrough infections.Read MoreACIP instead limited its recommendation to people over 50 with such conditions after members expressed doubts about recommending boosters too broadly.
Members were less enthusiastic about this option. Vaccine advisers next voted 9-6 Thursday to allow younger adults, those ages 18 to 49, to get a Covid-19 vaccine dose if they have underlying health conditions. A CDC analysis showed it was much more beneficial to give a booster dose to people 65 and older than to people in younger age groups.After CDC Director Dr. Rochelle Walensky signs off on the ACIP recommendations, booster shots may be given immediately.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19 live updates: CDC advisory panel expected to vote on Pfizer booster within hoursThe CDC’s independent advisory panel is set to vote this afternoon on which Americans are eligible now for a Pfizer booster.
Read more »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Read more »
Covid-19: NI records four Covid-linked deaths, 1,060 casesThe total number of deaths linked to coronavirus in NI since the start of the pandemic is 2,517.
Read more »
FDA authorizes Pfizer COVID-19 booster shots for someThe Food and Drug Administration granted emergency use authorization Wednesday for a third dose of Pfizer and BioNTech's COVID-19 vaccine to be given to three groups.
Read more »
FDA backs Pfizer COVID-19 boosters for seniors, high-riskThe U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19.
Read more »
FDA authorizes Pfizer-BioNTech booster shot for elderly, people at high risk of severe Covid-19Pfizer-BioNTech booster shots are now authorized by the FDA for people 65 and older and for certain high-risk adult populations
Read more »